Check-Cap (NASDAQ:CHEK) Stock Passes Above 50-Day Moving Average – Should You Sell?

Check-Cap Ltd. (NASDAQ:CHEK)’s share price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.77 and traded as high as $2.01. Check-Cap shares last traded at $1.9750, with a volume of 205,987 shares.

Wall Street Analysts Forecast Growth

CHEK has been the subject of several recent analyst reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Check-Cap in a research note on Wednesday, October 8th. Wall Street Zen raised shares of Check-Cap to a “hold” rating in a report on Saturday. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Check-Cap Stock Performance

The company has a market capitalization of $11.56 million, a price-to-earnings ratio of -0.71 and a beta of 0.41. The business has a 50 day moving average price of $1.77 and a 200-day moving average price of $1.12.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.